Biotech · Private company
Repare Therapeutics
Track this companyFree. Adds Repare Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials81 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Gemcitabine InjectionPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- RP-3500 (camonsertib)Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- RP-3500 (camonsertib)Phase 2 · Advanced Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- TalazoparibPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Olaparib 200-300 mg BID, dailyPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- RP-1664Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- RP-3467 at assigned dose and schedulePhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Phase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid TumorsPHASE1 · TERMINATED · started Sep 17, 2024ClinicalTrials.gov NCT06560632 · fetched Nov 12, 2026
- LIONS (PLK4 Inhibitor in Advanced Solid Tumors)PHASE1 · TERMINATED · started Feb 14, 2024ClinicalTrials.gov NCT06232408 · fetched Nov 12, 2026
- A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor CancerPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 30, 2022ClinicalTrials.gov NCT05566574 · fetched Nov 12, 2026
- RP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic LeukemiaPHASE1_PHASE2 · TERMINATED · started Sep 23, 2022ClinicalTrials.gov NCT05405309 · fetched Nov 12, 2026
- Study of RP-6306 With FOLFIRI in Advanced Solid TumorsPHASE1 · TERMINATED · started Aug 9, 2022ClinicalTrials.gov NCT05147350 · fetched Nov 12, 2026
- Study of RP-6306 With Gemcitabine in Advanced Solid TumorsPHASE1 · TERMINATED · started Dec 16, 2021ClinicalTrials.gov NCT05147272 · fetched Nov 12, 2026
- Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid TumorsPHASE1_PHASE2 · TERMINATED · started Jul 21, 2021ClinicalTrials.gov NCT04972110 · fetched Nov 12, 2026
- Study of RP-3500, Camonsertib, in Advanced Solid TumorsPHASE1_PHASE2 · COMPLETED · started Jul 22, 2020ClinicalTrials.gov NCT04497116 · fetched Nov 12, 2026